July 9, 2026 · Form 4 insider transaction
MCLAUGHLIN JOHN bought 10,000 shares of Sonoma Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors.; The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control.